Cargando…
Natural Progression of Routine Laboratory Markers after Spinal Trauma: A Longitudinal, Multi-Cohort Study
Our objective was to track and quantify the natural course of serological markers over the 1st year following spinal cord injury. For that purpose, data on serological markers, demographics, and injury characteristics were extracted from medical records of a clinical trial (Sygen) and an ongoing obs...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc., publishers
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8309438/ https://www.ncbi.nlm.nih.gov/pubmed/33882712 http://dx.doi.org/10.1089/neu.2021.0012 |
_version_ | 1783728521676324864 |
---|---|
author | Bourguignon, Lucie Vo, Anh Khoa Tong, Bobo Geisler, Fred Mach, Orpheus Maier, Doris Kramer, John L.K. Grassner, Lukas Jutzeler, Catherine R. |
author_facet | Bourguignon, Lucie Vo, Anh Khoa Tong, Bobo Geisler, Fred Mach, Orpheus Maier, Doris Kramer, John L.K. Grassner, Lukas Jutzeler, Catherine R. |
author_sort | Bourguignon, Lucie |
collection | PubMed |
description | Our objective was to track and quantify the natural course of serological markers over the 1st year following spinal cord injury. For that purpose, data on serological markers, demographics, and injury characteristics were extracted from medical records of a clinical trial (Sygen) and an ongoing observational cohort study (Murnau study). The primary outcomes were concentration/levels/amount of commonly collected serological markers at multiple time points. Two-way analysis of variance (ANOVA) and mixed-effects regression techniques were used to account for the longitudinal data and adjust for potential confounders. Trajectories of serological markers contained in both data sources were compared using the slope of progression. Our results show that, at baseline (≤ 2 weeks post-injury), most serological markers were at pathological levels, but returned to normal values over the course of 6–12 months post-injury. The baseline levels and longitudinal trajectories were dependent on injury severity. More complete injuries were associated with more pathological values (e.g., hematocrit, ANOVA test; χ(2) = 68.93, df = 3, adjusted p value <0.001, and χ(2) = 73.80, df = 3, adjusted p value <0.001, in the Sygen and Murnau studies, respectively). Comparing the two databases revealed some differences in the serological markers, which are likely attributable to differences in study design, sample size, and standard of care. We conclude that because of trauma-induced physiological perturbations, serological markers undergo marked changes over the course of recovery, from initial pathological levels that normalize within a year. The findings from this study are important, as they provide a benchmark for clinical decision making and prospective clinical trials. All results can be interactively explored on the Haemosurveillance web site (https://jutzelec.shinyapps.io/Haemosurveillance/) and GitHub repository (https://github.com/jutzca/Systemic-effects-of-Spinal-Cord-Injury). |
format | Online Article Text |
id | pubmed-8309438 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Mary Ann Liebert, Inc., publishers |
record_format | MEDLINE/PubMed |
spelling | pubmed-83094382021-07-26 Natural Progression of Routine Laboratory Markers after Spinal Trauma: A Longitudinal, Multi-Cohort Study Bourguignon, Lucie Vo, Anh Khoa Tong, Bobo Geisler, Fred Mach, Orpheus Maier, Doris Kramer, John L.K. Grassner, Lukas Jutzeler, Catherine R. J Neurotrauma Original Articles Our objective was to track and quantify the natural course of serological markers over the 1st year following spinal cord injury. For that purpose, data on serological markers, demographics, and injury characteristics were extracted from medical records of a clinical trial (Sygen) and an ongoing observational cohort study (Murnau study). The primary outcomes were concentration/levels/amount of commonly collected serological markers at multiple time points. Two-way analysis of variance (ANOVA) and mixed-effects regression techniques were used to account for the longitudinal data and adjust for potential confounders. Trajectories of serological markers contained in both data sources were compared using the slope of progression. Our results show that, at baseline (≤ 2 weeks post-injury), most serological markers were at pathological levels, but returned to normal values over the course of 6–12 months post-injury. The baseline levels and longitudinal trajectories were dependent on injury severity. More complete injuries were associated with more pathological values (e.g., hematocrit, ANOVA test; χ(2) = 68.93, df = 3, adjusted p value <0.001, and χ(2) = 73.80, df = 3, adjusted p value <0.001, in the Sygen and Murnau studies, respectively). Comparing the two databases revealed some differences in the serological markers, which are likely attributable to differences in study design, sample size, and standard of care. We conclude that because of trauma-induced physiological perturbations, serological markers undergo marked changes over the course of recovery, from initial pathological levels that normalize within a year. The findings from this study are important, as they provide a benchmark for clinical decision making and prospective clinical trials. All results can be interactively explored on the Haemosurveillance web site (https://jutzelec.shinyapps.io/Haemosurveillance/) and GitHub repository (https://github.com/jutzca/Systemic-effects-of-Spinal-Cord-Injury). Mary Ann Liebert, Inc., publishers 2021-08-01 2021-07-15 /pmc/articles/PMC8309438/ /pubmed/33882712 http://dx.doi.org/10.1089/neu.2021.0012 Text en © Lucie Bourguignon et al., 2021; Published by Mary Ann Liebert, Inc. https://creativecommons.org/licenses/by-nc/4.0/This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (CC-BY-NC) (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited. |
spellingShingle | Original Articles Bourguignon, Lucie Vo, Anh Khoa Tong, Bobo Geisler, Fred Mach, Orpheus Maier, Doris Kramer, John L.K. Grassner, Lukas Jutzeler, Catherine R. Natural Progression of Routine Laboratory Markers after Spinal Trauma: A Longitudinal, Multi-Cohort Study |
title | Natural Progression of Routine Laboratory Markers after Spinal Trauma: A Longitudinal, Multi-Cohort Study |
title_full | Natural Progression of Routine Laboratory Markers after Spinal Trauma: A Longitudinal, Multi-Cohort Study |
title_fullStr | Natural Progression of Routine Laboratory Markers after Spinal Trauma: A Longitudinal, Multi-Cohort Study |
title_full_unstemmed | Natural Progression of Routine Laboratory Markers after Spinal Trauma: A Longitudinal, Multi-Cohort Study |
title_short | Natural Progression of Routine Laboratory Markers after Spinal Trauma: A Longitudinal, Multi-Cohort Study |
title_sort | natural progression of routine laboratory markers after spinal trauma: a longitudinal, multi-cohort study |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8309438/ https://www.ncbi.nlm.nih.gov/pubmed/33882712 http://dx.doi.org/10.1089/neu.2021.0012 |
work_keys_str_mv | AT bourguignonlucie naturalprogressionofroutinelaboratorymarkersafterspinaltraumaalongitudinalmulticohortstudy AT voanhkhoa naturalprogressionofroutinelaboratorymarkersafterspinaltraumaalongitudinalmulticohortstudy AT tongbobo naturalprogressionofroutinelaboratorymarkersafterspinaltraumaalongitudinalmulticohortstudy AT geislerfred naturalprogressionofroutinelaboratorymarkersafterspinaltraumaalongitudinalmulticohortstudy AT machorpheus naturalprogressionofroutinelaboratorymarkersafterspinaltraumaalongitudinalmulticohortstudy AT maierdoris naturalprogressionofroutinelaboratorymarkersafterspinaltraumaalongitudinalmulticohortstudy AT kramerjohnlk naturalprogressionofroutinelaboratorymarkersafterspinaltraumaalongitudinalmulticohortstudy AT grassnerlukas naturalprogressionofroutinelaboratorymarkersafterspinaltraumaalongitudinalmulticohortstudy AT jutzelercatheriner naturalprogressionofroutinelaboratorymarkersafterspinaltraumaalongitudinalmulticohortstudy |